These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24575976)

  • 1. Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells.
    Wang R; Cheng L; Xia J; Wang Z; Wu Q; Wang Z
    Curr Cancer Drug Targets; 2014; 14(4):407-17. PubMed ID: 24575976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
    Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
    Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
    Ma J; Fang B; Zeng F; Ma C; Pang H; Cheng L; Shi Y; Wang H; Yin B; Xia J; Wang Z
    Oncotarget; 2015 Jan; 6(3):1740-9. PubMed ID: 25638153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
    Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.
    Lee JE; Kang YW; Jung KH; Son MK; Shin SM; Kim JS; Kim SJ; Fang Z; Yan HH; Park JH; Yoon YC; Han B; Cheon MJ; Woo MG; Seo MS; Lim JH; Kim YS; Hong SS
    Cancer Lett; 2021 Jun; 507():97-111. PubMed ID: 33744388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer.
    Liu YF; Luo D; Li X; Li ZQ; Yu X; Zhu HW
    Pancreas; 2021 Feb; 50(2):227-234. PubMed ID: 33565800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
    Arora S; Bhardwaj A; Singh S; Srivastava SK; McClellan S; Nirodi CS; Piazza GA; Grizzle WE; Owen LB; Singh AP
    J Biol Chem; 2013 Jul; 288(29):21197-21207. PubMed ID: 23740244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
    Ni J; Zhou S; Yuan W; Cen F; Yan Q
    J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer.
    Kasuya K; Tsuchida A; Nagakawa Y; Suzuki M; Abe Y; Itoi T; Serizawa H; Nagao T; Shimazu M; Aoki T
    Oncol Rep; 2011 Dec; 26(6):1399-406. PubMed ID: 21922147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.
    Namba T; Kodama R; Moritomo S; Hoshino T; Mizushima T
    Cell Death Dis; 2015 Jun; 6(6):e1795. PubMed ID: 26111057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.
    Wang Z; Li Y; Kong D; Banerjee S; Ahmad A; Azmi AS; Ali S; Abbruzzese JL; Gallick GE; Sarkar FH
    Cancer Res; 2009 Mar; 69(6):2400-7. PubMed ID: 19276344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells.
    Tsukasa K; Ding Q; Yoshimitsu M; Miyazaki Y; Matsubara S; Takao S
    Hum Cell; 2015 Oct; 28(4):167-74. PubMed ID: 25997702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer.
    Zhao T; Jin F; Xiao D; Wang H; Huang C; Wang X; Gao S; Liu J; Yang S; Hao J
    Theranostics; 2020; 10(9):4088-4100. PubMed ID: 32226541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line.
    Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Umebayashi M; Morisaki T; Hasumi K
    Anticancer Res; 2016 Feb; 36(2):653-7. PubMed ID: 26851020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.
    Zhao H; Duan Q; Zhang Z; Li H; Wu H; Shen Q; Wang C; Yin T
    J Cell Mol Med; 2017 Sep; 21(9):2055-2067. PubMed ID: 28244691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of gemcitabine-resistant pancreatic tumor cells.
    Shah AN; Summy JM; Zhang J; Park SI; Parikh NU; Gallick GE
    Ann Surg Oncol; 2007 Dec; 14(12):3629-37. PubMed ID: 17909916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
    Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
    El Amrani M; Corfiotti F; Corvaisier M; Vasseur R; Fulbert M; Skrzypczyk C; Deshorgues AC; Gnemmi V; Tulasne D; Lahdaoui F; Vincent A; Pruvot FR; Van Seuningen I; Huet G; Truant S
    Mol Carcinog; 2019 Nov; 58(11):1985-1997. PubMed ID: 31373074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.